Skip to content

Ascentage Pharma

US · AAPG #3045 by market cap Listed 2025
14.94 -1.15 -7.15%
Live - 5344 symbols - heartbeat 192s ago · 2026-10-08 05:05
Pre-market 14.71 -1.54%
After-hours 14.94 0.00%
Overnight 14.70 -1.61%
Market cap
1.40B
P/B
16.81
EPS
-1.99
Reader sentiment Are you bullish or bearish on AAPG?

Anonymous reader poll. Unscientific, not investment advice.

Ascentage Pharma ended the session at 14.94, down 7.15%. At current prices, the business is worth about 1.40B, the #3045 most valuable US-listed company we track. Wall Street's 4-analyst consensus lands on Buy, with a price target averaging 46.00 (+208% from here). Over the past year the stock has ranged from 14.55 to 37.50; it now sits 2% up that band.

✦ StockVane Quant Insights how this is computed

Quant Rating E Strong Sell
  • Below its 200-day average and near the bottom of the universe on momentum.
  • Signal has read STRONG SELL for 4 months.
See the full rating history & follow-along return →
Quant Sentiment Neutral
  • Recent price momentum is -40.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

27.4014.6114.942026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -8.40%
1M -15.19%
3M -20.02%
6M -45.33%
YTD -43.06%
1Y -61.57%

Key statistics

Price & volume

Prev close
16.09
Open
15.14
Day range
14.85 - 15.40
Avg price
15.07
Volume
7.24K
Turnover
109.15K
Amplitude
3.42%
52-week range
14.55 - 37.50

Valuation

P/E
-7.52
P/E (TTM)
-6.37
P/B
16.81
EPS
-1.99
Net profit
-185.47M
Net assets
83.02M

Share structure

Market cap
1.40B
Float cap
1.07B
Shares out
93.39M
Float shares
71.93M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2025-01-24
52-week range 2% of range
14.55 37.50

60.2% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-28.89K net over the window

Short interest

Shares short
19.86K
As of
2026-09-15

Frequently asked questions

What is the current stock price of Ascentage Pharma (AAPG)?

Ascentage Pharma last traded at 14.94. The quote on this page refreshes every few seconds while US markets are open.

What is Ascentage Pharma's market cap?

About 1.40B.

What is the P/E ratio of Ascentage Pharma?

The trailing twelve-month P/E is -6.37. The Valuation tab shows it against the stock's own five-year range.

Does Ascentage Pharma pay a dividend?

Ascentage Pharma does not currently pay a regular dividend.

Is Ascentage Pharma a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 46.00, which implies 207.9% upside from the current price. This is not investment advice.

What is Ascentage Pharma's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Ascentage Pharma a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-10-08 05:05:11 · For reference only, not investment advice and not tailored to your situation.